慢性阻塞性肺疾病住院后第一年再入院与死亡的风险轨迹
该研究基于美国医疗保险受益人(≥65岁)数据,分析COPD出院后1年内每日再入院和死亡的绝对风险,并按通气支持方式分层。在2,340,637例次住院中,1年再入院率为64.2%(有创通气63.5%、无创通气66.0%、无通气64.1%);在1,283,069例次住院中,1年死亡率为26.2%(有创通气45.7%、无创通气41.8%、无通气24.4%)。再入院日风险在有创、无创、无通气组分别于28、39、43天下降50%,于46、54、61天进入平台期;死亡日风险分别于3、4、17天下降50%,于21、18、24天进入平台期。COPD出院后再入院和死亡风险显著高于一般老年人群,提示仅限出院后第一个月的干预可能不足以改善长期结局。
要点
- COPD出院后1年再入院率64.2%,其中有创通气63.5%、无创通气66.0%、无通气64.1%。
- COPD出院后1年死亡率26.2%,其中有创通气45.7%、无创通气41.8%、无通气24.4%。
- 再入院日风险下降50%所需时间:有创通气28天、无创通气39天、无通气43天。
- 死亡日风险下降50%所需时间:有创通气3天、无创通气4天、无通气17天。
- 作者认为仅限出院后第一个月的干预可能不足以改善长期结局。
适用人群与场景
- 美国医疗保险受益人,年龄65岁及以上,因慢性阻塞性肺疾病住院后出院。
- 按出院时通气支持方式分为有创通气、无创通气、无通气三组。
研究设计与关键结果
- 研究类型为基于美国医疗保险受益人的风险轨迹分析,纳入2,340,637例次住院分析再入院,1,283,069例次住院分析死亡。
- 1年再入院率64.2%,其中有创通气63.5%、无创通气66.0%、无通气64.1%。
- 1年死亡率26.2%,其中有创通气45.7%、无创通气41.8%、无通气24.4%。
- 再入院日风险下降50%所需时间:有创通气28天、无创通气39天、无通气43天;进入平台期时间分别为46、54、61天。
- 死亡日风险下降50%所需时间:有创通气3天、无创通气4天、无通气17天;进入平台期时间分别为21、18、24天。
- COPD出院后再入院和死亡风险显著高于一般医疗保险老年人群。
证据类型、等级与局限
- 证据类型:基于美国医疗保险受益人的观察性风险轨迹分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为仅限出院后第一个月的干预可能不足以改善COPD出院后的长期结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Characterization of the dynamic nature of posthospital risk in chronic obstructive pulmonary disease (COPD) is needed to provide counseling and plan clinical services.
OBJECTIVES: To analyze risk of readmission and death after discharge for COPD among Medicare beneficiaries aged 65 years and older and to determine the association between ventilator support and risk trajectory.
METHODS: We computed daily absolute risks of hospital readmission and death for 1 year after discharge for COPD, stratified by ventilator support. We determined the time required for risks to decline by 50% from maximum daily values after discharge and for daily risks to plateau. We compared risks with those found in the general elderly population.
MEASUREMENTS AND MAIN RESULTS: Among 2,340,637 hospitalizations, the readmission rate at 1 year was 64.2%, including 63.5%, 66.0%, and 64.1% among those receiving invasive, noninvasive, and no ventilation, respectively. Among 1,283,069 hospitalizations, mortality at 1 year was 26.2%, including 45.7%, 41.8%, and 24.4% among those same respective groups. Daily risk of readmission declined by 50% within 28, 39, and 43 days and plateaued at 46, 54, and 61 days among those receiving invasive, noninvasive, and no ventilation, respectively. Risk of death declined by 50% by 3, 4, and 17 days and plateaued by 21, 18, and 24 days in the same respective groups. Risks of hospitalization and death were significantly higher after discharge for COPD than among the general Medicare population.
CONCLUSIONS: Discharge from the hospital is associated with prolonged risks of readmission and death that vary with need for ventilator support. Interventions limited to the first month after discharge may be insufficient to improve longitudinal outcomes.
参考来源
- Lindenauer PK, Dharmarajan K, Qin L, et al. Risk Trajectories of Readmission and Death in the First Year after Hospitalization for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018. PMID: 29206052. doi:10.1164/rccm.201709-1852OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。